These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2468272)

  • 1. Dihydrotestosterone measured in core biopsies from prostatic tissues.
    Bruun E; Frandsen H; Nielsen K; Rasmussen LB; Vinnergaard T; Frimodt-Møller C
    Am J Clin Oncol; 1988; 11 Suppl 2():S27-9. PubMed ID: 2468272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on usefulness of the crude nuclear DHT measurement in prostatic cancer patients].
    Tohjoh S
    Nihon Hinyokika Gakkai Zasshi; 1989 Sep; 80(9):1327-35. PubMed ID: 2480469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone-dependency of the human prostate].
    Robel P
    Bull Cancer; 1986; 73(1):19-22. PubMed ID: 2430651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
    Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
    J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endogenous androgen levels of human prostatic tissues].
    Morioka M; Takeda K; Mitsuhata N; Ohashi T; Ohmori H; Saito T; Kanbegawa A
    Nihon Naibunpi Gakkai Zasshi; 1982 Jul; 58(7):876-85. PubMed ID: 6182032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHT concentrations in human prostate cancer tissue.
    Geller J; Albert J; Loza D; Geller S; Stoeltzing W; de la Vega D
    J Clin Endocrinol Metab; 1978 Mar; 46(3):440-4. PubMed ID: 87401
    [No Abstract]   [Full Text] [Related]  

  • 7. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression.
    Shiina H; Igawa M; Ishibe T
    Br J Urol; 1996 Jan; 77(1):96-101. PubMed ID: 8653325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodologic basis for the radioimmunoassay of endogenous steroids in human prostatic tissue.
    Belis JA
    Invest Urol; 1980 Jan; 17(4):332-6. PubMed ID: 6153177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of testosterone and its tissue metabolites (DHT and 3 alpha-diol) in human plasma and prostatic tissue by isotopic dilution mass spectrometry.
    Moneti G; Giovannini MG; Guarna A; Forti G; Salerno R; Magini A; Serio M
    J Steroid Biochem; 1987; 27(1-3):53-9. PubMed ID: 2447389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
    Habib FK; Lee IR; Stitch SR; Smith PH
    J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer of the prostate: early diagnosis by zinc and hormone analysis?
    Habib FK; Mason MK; Smith PH; Stitch SR
    Br J Cancer; 1979 Jun; 39(6):700-4. PubMed ID: 87214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
    Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
    Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
    Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
    Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear androgen receptor content in biopsy specimens from histologically normal, hyperplastic, and cancerous human prostatic tissue.
    van Aubel OG; Bolt-de Vries J; Blankenstein MA; ten Kate FJ; Schröder FH
    Prostate; 1985; 6(2):185-94. PubMed ID: 2579371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor in electroresected and cold punch-resected specimens. Usefulness of Kaplan cold punch resectoscope.
    Kitano T; Usui T; Yasukawa A; Nakahara M; Nihira H; Miyachi Y
    Urology; 1983 Feb; 21(2):119-22. PubMed ID: 6186065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy.
    Geller J; Albert J; Nachtsheim D; Loza D; Lippman S
    Prog Clin Biol Res; 1979; 33():103-11. PubMed ID: 93747
    [No Abstract]   [Full Text] [Related]  

  • 20. Nuclear androgen receptors of human prostatic tissue--a quantitative histological study.
    Elhilali M; Lehoux JG; Carmel M; Madarnas P; Mongeau C; Beauchesne C; Tétreault L; Bénard B
    Arch Androl; 1983 Mar; 10(1):21-7. PubMed ID: 6189463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.